Form D · Investing
Neopharm III Series, a separate series of Granite Hall Master Fund Series LLC
Chicago, IL · CIK 0001749931
Offering snapshot reported Aug 13, 2018 · SEC filing
- Reported sold
- $2.2M Offering amount: $5M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 6, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2018 | Initial | $2,200,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-319022
Source: Form D, filed Aug 13, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J Patrick Barry | Executive |
Issuer details
Industry: Investing (See others in industry)
Address:
300 S. Wacker Drive Suite 2750
Chicago, IL, 60606
Chicago, IL, 60606